data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Orgenesis
(NASDAQ:ORGS)
$2.30
-0.12[-4.96%]
At close: Jul 1
$2.41
0.1100[4.78%]
After Hours: 5:31PM EDT
Day High/Low2.18 - 2.45
52 Week High/Low1.77 - 5.49
Open / Close2.45 / 2.3
Float / Outstanding24.5M / 24.8M
Vol / Avg.20.9K / 41.3K
Mkt Cap57.1M
P/E-
50d Avg. Price2.58
Div / Yield-
Payout Ratio-
EPS-0.16
Total Float24.5M

Orgenesis (NASDAQ:ORGS), Quotes and News Summary

Orgenesis (NASDAQ: ORGS)

Day High/Low2.18 - 2.45
52 Week High/Low1.77 - 5.49
Open / Close2.45 / 2.3
Float / Outstanding24.5M / 24.8M
Vol / Avg.20.9K / 41.3K
Mkt Cap57.1M
P/E-
50d Avg. Price2.58
Div / Yield-
Payout Ratio-
EPS-0.16
Total Float24.5M
Benzinga - May 24, 2022, 7:08AM
Benzinga - May 3, 2022, 6:58AM
Benzinga - Mar 30, 2022, 7:15AM
Benzinga - Jan 27, 2022, 7:41AM
Benzinga - Jan 18, 2022, 7:38AM
Benzinga - Nov 29, 2021, 12:47PM
Benzinga - Nov 29, 2021, 7:07AM
Benzinga - Nov 4, 2021, 8:18AM
Benzinga - Aug 23, 2021, 8:07AM
Benzinga - Aug 5, 2021, 7:51AM
Benzinga - Jul 6, 2021, 7:06AM
Sector: Health Care.Industry: Biotechnology
Orgenesis Inc is a global biotech company working to unlock the potential of cell and gene therapies. It is focused on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient for treatment of the patient at the point of care (POCare). Its geographical segments include Korea, United Arab Emirates, China, India, and Greece.
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-04
REV
Q1 2022Est.ActualSurprise
EPS-0.040-0.160 -0.1200
REV7.212M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Orgenesis Questions & Answers

Q
How do I buy Orgenesis (ORGS) stock?
A

You can purchase shares of Orgenesis (NASDAQ: ORGS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Orgenesis's (ORGS) competitors?
Q
What is the target price for Orgenesis (ORGS) stock?
A

The latest price target for Orgenesis (NASDAQ: ORGS) was reported by Benchmark on Thursday, September 26, 2019. The analyst firm set a price target for 9.00 expecting ORGS to rise to within 12 months (a possible 291.30% upside). 0 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Orgenesis (ORGS)?
A

The stock price for Orgenesis (NASDAQ: ORGS) is $2.3 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Orgenesis (ORGS) pay a dividend?
A

There are no upcoming dividends for Orgenesis.

Q
When is Orgenesis (NASDAQ:ORGS) reporting earnings?
A

Orgenesis’s Q2 earnings are confirmed for Thursday, August 4, 2022.

Q
Is Orgenesis (ORGS) going to split?
A

There is no upcoming split for Orgenesis.

Q
What sector and industry does Orgenesis (ORGS) operate in?
A

Orgenesis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.